Kusurinomadoguchi, Inc. (TYO:5592)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Develops and Sells Pharmacies and Medical Solutions	11.20B	8.72B	7.42B
Develops and Sells Pharmacies and Medical Solutions Growth	28.41%	17.53%	-
Total	11.20B	8.72B	7.42B
Total Growth	28.41%	17.53%	-

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Japan	11.20B	8.72B	7.42B
Japan Growth	28.41%	17.53%	-
Total	11.20B	8.72B	7.42B
Total Growth	28.41%	17.53%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error